Cargando…

Preliminary assessment of anti-α-Gal IgG and IgM levels in patients with patent Plasmodium vivax infection

Anti-α-Gal responses may exert a protective effect in falciparum malaria. However, the biological role of such antibodies is still unknown during Plasmodium vivax infections. We investigated IgG and IgM responses to α-Gal in individuals with vivax malaria. Anti-α-Gal IgG and IgM levels were higher i...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Zélia Barbosa de Almeida, Mourão, Luiza Carvalho, Rodrigues, Beatriz Carolina Medeiros, Cardoso-Oliveira, Gustavo Pereira, Hincapie, Robert, Sanhueza-Chavez, Carlos, Finn, MG, Fontes, Cor Jesus Fernandes, Marques, Alexandre Ferreira, Braga, Érika Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611334/
https://www.ncbi.nlm.nih.gov/pubmed/31291383
http://dx.doi.org/10.1590/0074-02760190145
Descripción
Sumario:Anti-α-Gal responses may exert a protective effect in falciparum malaria. However, the biological role of such antibodies is still unknown during Plasmodium vivax infections. We investigated IgG and IgM responses to α-Gal in individuals with vivax malaria. Anti-α-Gal IgG and IgM levels were higher in these patients than in controls, but no significant correlation was found between parasitaemia and anti-α-Gal response, nor between this response and ABO blood group status. This is the first study to investigate anti-α-Gal antibodies in P. vivax-infected patients; a larger survey is necessary to achieve a better understanding of host immune response during vivax malaria.